Rothschild Investment LLC Buys 146 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Rothschild Investment LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,399 shares of the healthcare conglomerate’s stock after acquiring an additional 146 shares during the period. Rothschild Investment LLC’s holdings in UnitedHealth Group were worth $3,237,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Accredited Investors Inc. grew its stake in UnitedHealth Group by 9,235.4% in the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its position in shares of UnitedHealth Group by 129.7% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after buying an additional 581,324 shares during the period. State Street Corp boosted its position in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of UnitedHealth Group during the third quarter worth about $276,785,000. Finally, Canoe Financial LP acquired a new position in shares of UnitedHealth Group during the third quarter worth about $216,166,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 7.3 %

Shares of NYSE:UNH opened at $465.58 on Monday. The stock’s 50-day moving average price is $519.27 and its 200-day moving average price is $560.44. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm earned $5.83 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

UNH has been the subject of several recent research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.